All attending UK organisations
UK companies attending as part of the official delegation
(Click here to search profiles)
To download the brochure, click here!
UK Exhibitors
BioPartner UK, NIHR and NOCRI : UK stand #19, CHASE #5b, Random42 #14.
Barrington James #105, Sekisui Diagnostics #23, One Nucleus #26, OBN #73.
BioConnection #23, Symbiosis #45, Sterling #47, FUJIFILM Diosynth Biotechnologies #80.
UK stand (booth 19):
BioPartner UK, NIHR, NOCRI
Almac Group, Almac Discovery, Bit Bio, Charnwood Molecular, Curileum Discovery, Evgen Pharma, Fusion Antibodies, InSilicoTrials Technologies, LSX, Medherant, MediWales, Mironid, Oncimmune, Precision for Medicine, Research Donors, Rosemont Pharmaceuticals, Scendea, Scottish Development International (SDI), Silence Therapeutics plc, UK BioIndustry Association (BIA), Pebmond Associates.
Regional Groups:
Scotland: Scottish Development International, CHASE, Mironid, Symbiosis Pharmaceutical Services, Ubiquigent
Northern Ireland: Almac Group, Almac Discovery, Fusion Antibodies, AilseVax, CV6 Therapeutics, Exploristics, pHion Therapeutics, Re-Vana Therapeutics, SiSaf, Sonrai Analytics
One Nucleus: Asahi Kasei Pharma Corporation, Curileum Discovery, DLRC, PrecisionLife, Precision for Medicine, Simbec-Orion, The Quadram Institute.
Other UK companies associated with the delegation*:
Arecor, BioLife Group, Ellipses Pharma, HistologiX, Mereo BioPharma, PharmaVentures Ltd, Present Value Limited, Ubiquigent, DIT, Avacta Life Sciences Limited, Intelligent Omics.
All attending UK companies:
272 Bio Limited, 42 Therapeutics, 4BIO Capital, Abcam, Absolute Antibody, Adaptimmune, Adrestia Therapeutics, Advanced Clinical, Advanz Pharma, Alacrita Consulting, Alchemab Therapeutics, Almac Discovery, Almac Group, AlphaSense, Amphista, Antibody Analytics, Apex Healthcare Consulting Limited, Apple Tree Life Sciences (UK) Limited, Aptamer Group, Arecor Limited, Arix Bioscience, Asieris Pharmaceutical, ASKA Pharmaceutical Co, Aspire pharma, Astellas Pharma, Aston Uni, AstraZeneca, Atheneum, Autolus, Avacta Life Sciences Limited, Barrington James, BenevolentAI, Bicycle Therapeutics, BioCentury, Biogen, BioLife Group, Biomage, BioPartner UK, Biopharma Excellence by PharmaLex, Biopharma Group, Bit Bio, Bristol-Myers Squibb Company, Cancer Research UK, CC Biotech, Charles River Associates, Charnwood Molecular, CHASE, Chiesi, Chugai Pharmaceutical Co, Citeline, Clinigen, Coulter Partners, Crescendo Biologics, Curileum Discovery, Daewoong Pharmaceutical Co, Department for International Trade, Destiny Pharma, DLRC, Domainex, Drug Development Solutions, éclateral, Edinburgh Molecular Imaging, Eisai Europe, Elasmogen, Eli Lilly and Company, Ellipses Pharma, Emergex Vaccines, EnteroBiotix, Erebagen, Esperante, Essential Pharma, Etcembly, Eurofins Discovery DiscoveryOne, Evaluate, Eversana, Evgen Pharma, Evotec International, Evox Therapeutics, Exploristics, Exscientia, F-Prime Capital, Ferghana Partners, Ferring, Forcefield Therapeutics, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, Galen, GlobalData, Gowling WLG, GSK, HealthCare Royalty Partners, Healx, Heptares Therapeutics, HistologiX, HungaroTrial CRO, HVIVO Services Limited - London, IAG (Image Analysis Group), ICR, ImaginAb, ImmTune Therapies, Imspex Diagnostics, IN-PART, Inizio, InSilicoTrials Technologies, Intelligent OMICS, invoX Pharma, Ipsen, IsomAb, Jazz Pharmaceuticals, Johnson & Johnson, KBio, Labcorp Drug Development, Life Sciences Recruitment, Lifearc, LifeSci Search, LiliumX, LoQus23 Therapeutics, LSX, Medherant, MediMab Biotherapeutics, MediWales, MedPharm, Merck, Mereo BioPharma, Mergermarket, MESOX (Spinout from Aston), Microbiotica, Midatech Pharma, Mills & Reeve LLP, Mironid, MitoRx Therapeutics Limited, Mitsubishi Tanabe Pharma Corporation, Monograph, Monument Tx, MSD, MultiOmic Health Limited, Myonex, Nanomerics, NanoSyrinx, National Institute for Health and Care Research (NIHR), Nevrargenics, NIHR Office for Clinical Research Infrastructure (NOCRI), Norgine Limited, Norgine Ventures Management Limited, Oak Hill Bio, OBN (UK), Ochre Bio, OMass Therapeutics, Oncimmune, One Nucleus, ONO Pharma, Oppilotech, Orbit Discovery, Ossianix, Otsuka Pharmaceutical, oval, Owkin, Oxford BioTherapeutics, OxSonics, Parkinson's Research Ventures, Pebmond Associates, Pencil Biosciences, Pharma Intelligence, PharmaCircle, Pharmanovia, PHARMASSIST, PharmaVentures, PharmEnable, PhoreMost, Physiomics, Poolbeg Pharma, Pracipio, Precision for Medicine, PrecisionLife, Present Value Limited, Prokarium, ProPharma Group, Quadram Institute Bioscience, Queen's University Belfast, Quotient Sciences, Rallybio, Random42, Randox Laboratories, RBW Consulting, Renata Limited, ReNewVax, Research Donors, Results, Rosemont Pharmaceuticals, Sartorius Stedim Biotech, Scendea, Scius Communications, Scottish Development International (SDI), Scrip, Sekisui, SGS, Shanghai Medicilon, Shionogi, Silence Therapeutics, Simbec-Orion, Simcere Pharma, SiSaf, Sitryx, SLA Pharma, SomaServe, Sonrai Analytics, Spirea, Springer Nature, Standigm, Sterling Technology, SynOx Therapeutics Limited, T-Cypher Bio, Tanner Pharma, The Fulford Group, The Institute of Cancer Research, The Sage Group, Theramex, tranScrip, Treehill Advisors LLP, Ubiquigent, UCB, UCLB, UK BioIndustry Association (BIA), University of Bradford, University of Dundee, University of Edinburgh, Vaccitech, ValiRx, VaxEquity, Veristat, Vernalis R&D, Virocell, WEP Clinical, WittKieffer International, WuXi AppTec, WuXi Biologics, X-Chem.
(237) correct as at 14th October 2022
Join them here!
